Anavex Life Sciences uplists to Nasdaq Global Select Market, ticker AVXL unchanged

ANAVEX LIFE SCIENCES CORP.

Common stock approved for listing on Nasdaq Global Select Market, effective September 27, 2021.
Previously traded on Nasdaq Capital Market; ticker symbol remains AVXL.
Uplisting reflects meeting Nasdaq Global Select Market's higher financial and liquidity requirements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.